Elsevier

Journal of Nuclear Cardiology

Volume 9, Issue 5, September 2002, Pages 515-522
Journal of Nuclear Cardiology

Original article
Comparison of the cost-effectiveness of stress myocardial SPECT and stress echocardiography in suspected coronary artery disease considering the prognostic value of false-negative results

https://doi.org/10.1067/mnc.2002.125217Get rights and content

Abstract

Background. The prognoses of patients with false-negative test results by myocardial single photon emission computed tomography (SPECT) and by stress echocardiography are known to be different; the prognosis with false-negative SPECT is better in suspected and proven coronary artery disease (CAD). Methods and Results. Three strategies by which to diagnose CAD were compared for their cost-effectiveness when considering the prognostic value of false-negative results: (1) stress myocardial SPECT by dipyridamole or adenosine followed by coronary angiography (CAG), (2) exercise stress echocardiography followed by CAG, and (3) dobutamine stress echocardiography followed by CAG. Delta quality-adjusted life-year (QALY) was calculated for the three strategies separately when annual mortality and infarction rates were 0.5% and 0.5% for myocardial SPECT and 2% and 2% for stress echocardiography, respectively. Costs were estimated and costs per ΔQALY were calculated according to the pretest likelihood of CAD (pCAD). The myocardial SPECT followed by CAG strategy was the most cost-effective in the patients with a pCAD of 0.3 or greater, and the dobutamine echocardiography followed by CAG strategy was the most cost-effective in patients with a pCAD of 0.2 or lower. This was the case when we assumed that the nondiagnostic test rate of dobutamine echocardiography was 9% (in contrast to 0% by myocardial SPECT and 18% by exercise echocardiography). Sensitivity analysis showed that the cost-effectiveness of dobutamine echocardiography followed by CAG was best only if the prognosis of false-negative results of dobutamine echocardiography was better. The cost-effectiveness of exercise echocardiography was dubious because of the high nondiagnostic rate with inadequate exercise. Conclusions. When the lower event rates of (false) negative SPECT were considered, the relatively expensive myocardial SPECT strategy was more cost-effective than the cheaper stress echocardiography strategy in patients with a pCAD of 0.3 or greater. According to sensitivity analysis, the prognostic value of false-negative results and the nondiagnostic test rate were important determinants of stress myocardial study cost-effectiveness. (J Nucl Cardiol 2002;9:515-22)

References (0)

Cited by (33)

  • Cost-Effectiveness and Future Implications for Cardiovascular Imaging

    2013, Canadian Journal of Cardiology
    Citation Excerpt :

    Simplistic examples of cost savings associated with index procedural costs can be short-sighted because there can be downstream-induced costs that offset any initial savings within a given episode of care. For example, within the diagnostic work-up of patients with suspected coronary artery disease (CAD), stress echocardiography27-29 or electrocardiography (ECG)26 are lower cost procedures when compared with stress myocardial perfusion single-photon emission CT (SPECT) or CMR. In a recent example, the lower cost, exercise ECG resulted in approximately 12% of women proceeding to a follow-up, myocardial perfusion SPECT scan at 1 year of follow-up.26

  • Cost-Effectiveness of Myocardial Perfusion Single-Photon Emission Computed Tomography

    2010, Clinical Nuclear Cardiology: State of the Art and Future Directions
  • The Prognostic Value of Normal Exercise Myocardial Perfusion Imaging and Exercise Echocardiography. A Meta-Analysis

    2007, Journal of the American College of Cardiology
    Citation Excerpt :

    Among these, 148 full-text articles evaluating the prognostic utility of exercise MPI or exercise echocardiography were reviewed, and 20 studies were found to be eligible for the systematic review. Of the 148 full-text articles reviewed, 17 did not address the research question (15–31), 18 were excluded because they used pharmacologic rather than exercise stress (32–49), 27 did not include primary data on event rates that could be combined in a meta-analysis (47,50–75), 16 did not address a population with known or suspected CAD (76–91), 5 evaluated only hospitalized patients or patients evaluated for chest pain syndromes in the emergency department (92–96), 16 included only patients with angiographically proven CAD or positive tests (97–112), 21 were potentially overlapping patient populations of other studies (53,113–132), 5 evaluated planar MPI (133–137), and 3 did not define a negative test as one without any abnormalities (138–140). Of the 17 studies included that evaluated MPI (141–156), 5 used thallium (143,147,153,154,157), 8 used sestamibi (141,142,146,148–150,152,156), 2 used both thallium and sestamibi (145,155), and 2 used tetrofosmin (144,151).

  • Nuclear cardiology, an evidence based sub-speciality

    2006, Revista Espanola de Medicina Nuclear
View all citing articles on Scopus
View full text